ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2014
Major emerging and re-emerging zoonoses in China: a matter of global health and socioeconomic development for 1.3 billion.
Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.Journal of nanobiotechnology · 2026Article
- Development of a non-invasive diagnostic method for pathogenic RNA viruses using sebum wiped from the cat's body surface.Scientific reports · 2026Article
- Exploratory metatranscriptomic survey of bat-associated RNA viruses in Quzhou city, China.Frontiers in veterinary science · 2026Article
- China's revised infectious diseases law: a step towards stronger global pandemic preparedness.The Lancet regional health. Western Pacific · 2025Article
- Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection.Viruses · 2024Article
- Modern technologies and solutions to enhance surveillance and response systems for emerging zoonotic diseases.Science in One Health · 2024Review
- Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis ofFrontiers in veterinary science · 2024Article
- Net benefit of smaller human populations to environmental integrity and individual health and wellbeing.Frontiers in public health · 2024Review
- Establishment and application of an iELISA detection method for measuring apical membrane antigen 1 (AMA1) antibodies of Toxoplasma gondii in cats.BMC veterinary research · 2023Article
- Seropositivity, Comparison Between the Efficiency of Serological Tests and Risk Factors of Brucella Infection in Small Ruminants with History of Abortion in the Afar Region of North-Eastern Ethiopia.Veterinary medicine (Auckland, N.Z.) · 2023Article
- Leveraging machine learning to assess market-level food safety and zoonotic disease risks in China.Scientific reports · 2022Article
- Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid.Journal of biological engineering · 2022Review
- Conspiratorial Attitude of the General Public in Jordan towards Emerging Virus Infections: A Cross-Sectional Study Amid the 2022 Monkeypox Outbreak.Tropical medicine and infectious disease · 2022Article
- An Overview of Anthropogenic Actions as Drivers for Emerging and Re-Emerging Zoonotic Diseases.Pathogens (Basel, Switzerland) · 2022Review
- Beneficial influence of single-stage posterior surgery for the treatment of lumbar brucella spondylitis combined with spondylolisthesis.Scientific reports · 2022Article
- The association between Toxoplasma infection and mortality: the NHANES epidemiologic follow-up study.Parasites & vectors · 2022Article
- Selected Livestock-Associated Zoonoses as a Growing Challenge for Public Health.Infectious disease reports · 2022Review
- Wild animal and zoonotic disease risk management and regulation in China: Examining gaps and One Health opportunities in scope, mandates, and monitoring systems.One health (Amsterdam, Netherlands) · 2021Review
- Unveiling the Gut Microbiota and Resistome of Wild Cotton Mice,Microbiology spectrum · 2021Article
- Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2.The Science of the total environment · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging and re-emerging zoonoses are a significant public health concern and cause considerable socioeconomic problems globally. The emergence of severe acute respiratory syndrome (SARS), highly pathogenic avian influenza (HPAI) H5N1, avian influenza H7N9, and severe fever with thrombocytopenia syndrome (SFTS), and the re-emergence of rabies, brucellosis, and other zoonoses have had a significant effect on the national economy and public health in China, and have affected other countries. Contributing factors that continue to affect emerging and re-emerging zoonoses in China include social and environmental factors and microbial evolution, such as population growth, urbanization, deforestation, livestock production, food safety, climate change, and pathogen mutation. The Chinese government has devised new strategies and has taken measures to deal with the challenges of these diseases, including the issuing of laws and regulations, establishment of disease reporting systems, implementation of special projects for major infectious diseases, interdisciplinary and international cooperation, exotic disease surveillance, and health education. These strategies and measures can serve as models for the surveillance and response to continuing threats from emerging and re-emerging zoonoses in other countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.